Today, On 6th May, The Chief Justice of India has agreed to hear a plea about potential side effects of the Covishield COVID-19 vaccine. Concerns include Thrombosis with Thrombocytopenia Syndrome (TTS), cardiovascular risks, and myocarditis. A petition seeks an expert panel to investigate the side effects and compensation for affected individuals. AstraZeneca faces lawsuits over TTS, but regulatory authorities emphasize the vaccine’s benefits.
![[BREAKING] Covishield & Heart Attack | Grieving Parents to Seek Justice in Court After AstraZeneca Confirms Vaccine Side Effects](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/05/Screenshot-2024-05-01-133608.png?resize=447%2C367&ssl=1)
The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca’s acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count.
